Rothschild Investment LLC Adma Biologics, Inc. Transaction History
Rothschild Investment LLC
- $1.53 Trillion
- Q3 2024
A detailed history of Rothschild Investment LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 235 shares of ADMA stock, worth $5,315. This represents 0.0% of its overall portfolio holdings.
Number of Shares
235
Previous 100
135.0%
Holding current value
$5,315
Previous $1.12 Million
320.21%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ADMA
# of Institutions
301Shares Held
180MCall Options Held
535KPut Options Held
21.2K-
Black Rock Inc. New York, NY18.6MShares$422 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$328 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA13.2MShares$298 Million0.03% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL8.93MShares$202 Million0.03% of portfolio
-
State Street Corp Boston, MA8.06MShares$182 Million0.0% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $4.44B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...